Englander Institute for Precision Medicine
Found 877 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2025
O'Boyle B, Yeung W, Lu JD, Katiyar S, Yaron-Barir TM, Johnson JL, Cantley LC, Kannan N.  2025.  An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.. Sci Signal. 18(885):eadt8686.
Gao VR, Yang R, Das A, Luo R, Luo H, McNally DR, Karagiannidis I, Rivas MA, Wang Z-M, Barisic D et al..  2025.  Author Correction: ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.. Nat Commun. 16(1):684.
Petroni G, Galassi C, Gouin KH, Chen H-H, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G et al..  2025.  Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.. Nat Cancer.
Khosravi P, Saikali S, Alipour A, Mohammadi S, Boger M, Diallo DM, Smith CJ, Moschovas MC, Hajirasouliha I, Hung AJ et al..  2025.  AutoRadAI: a versatile artificial intelligence framework validated for detecting extracapsular extension in prostate cancer.. Biol Methods Protoc. 10(1):bpaf032.
Bellmunt J, Powles T, Park SHoon, Voog E, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N et al..  2025.  Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease.. Eur Urol.
Meleshko D, Yang R, Maharjan S, Danko DC, Korobeynikov A, Hajirasouliha I.  2025.  Blackbird: structural variant detection using synthetic and low-coverage long-reads.. Bioinform Adv. 5(1):vbaf151.
Powles T, Sridhar SS, Bellmunt J, Sternberg CN, Grivas P, Hunter E, Salter M, Powell R, Dring A, Green J et al..  2025.  Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.. Cancers (Basel). 17(14)
Moothedan E, Boyer M, Watts S, Abdel-Aty Y, Ghosh S, Rameau A, Sigaras A, Elemento O, Bensoussan Y.  2025.  The Bridge2AI-voice application: initial feasibility study of voice data acquisition through mobile health.. Front Digit Health. 7:1514971.
Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, Perez Dde Miguel, Venetis K, Dipasquale A, Ghazali N et al..  2025.  Cancer in a drop: Advances in liquid biopsy in 2024.. Crit Rev Oncol Hematol. 213:104776.
Martinelli C, Borea R, Shivahamy M, Dipasquale A, Saldanha EF, Ghazali N, Nicolo E, Stejskal P, Pontolillo L, Reduzzi C.  2025.  Cancer in a drop: Liquid biopsy highlights from the American Society of Clinical Oncology (ASCO) 2025 annual congress.. J Liq Biopsy. 9:100320.
Maheswaran S, Borea R, Perez Dde Miguel, Pisapia P, Ghazali N, Martinelli C, Stejskal P, Reduzzi C.  2025.  Cancer in a Drop: Liquid biopsy insights from AACR 2025.. J Liq Biopsy. 8:100304.
Razavian N, Batchu-Green P, Chowdhry V, Elemento O, Rajpurkar P, Saria S, Shah NH, Topol EJ.  2025.  Catalyzing Health AI by Fixing Payment Systems.. NEJM AI. 2(12)
Longoria O, Rekowski J, Gupta S, Beije N, Pantel K, Efstathiou E, Sternberg C, Castellano D, Fizazi K, Tombal B et al..  2025.  Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancer.. JCI Insight.
Teng M, Guo J, Xu X, Ci X, Mo Y, Kohen Y, Ni Z, Chen S, Guo WYuan, Bakht M et al..  2025.  Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.. Cancer Cell.
Kadri S, Craven KE, Fussell AM, Gee EPS, Jordan D, Klee EW, Krumm N, Temple-Smolkin RL, Zehir A, Zhang W et al..  2025.  Clinical Bioinformatician Body of Knowledge-Bioinformatics and Software Core: A Report of the Association for Molecular Pathology.. J Mol Diagn.
Agarwal PK, Sternberg CN.  2025.  Clinical trials corner issue 11(1).. Bladder Cancer. 11(1):23523735241309418.
Nauseef JT, Chu TR, Hooper WF, Alonso A, Oku A, Geiger H, Goldstein ZR, Shah M, Sigouros M, Manohar J et al..  2025.  A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.. NPJ Precis Oncol. 9(1):91.
Müller-Dott S, Jaehnig EJ, Munchic KPham, Jiang W, Yaron-Barir TM, Savage SR, Garrido-Rodriguez M, Johnson JL, Lussana A, Petsalaki E et al..  2025.  Comprehensive evaluation of phosphoproteomic-based kinase activity inference.. Nat Commun. 16(1):4771.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..  2025.  Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 5(1):11.
Chew SMei, Teumer A, Matías-García PR, Gieger C, Winckelmann J, Suhre K, Herder C, Rathmann W, Peters A, Waldenberger M.  2025.  Cross-sectional and longitudinal association of seven DNAm-based predictors with metabolic syndrome and type 2 diabetes.. Clin Epigenetics. 17(1):58.
Jiang W, Jaehnig EJ, Liao Y, Shi Z, Yaron-Barir TM, Johnson JL, Cantley LC, Zhang B.  2025.  Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites.. Nat Commun. 16(1):2766.
Kim YE, Dobko M, Li H, Shao T, Periyakoil P, Tipton C, Colasacco C, Serpedin A, Elemento O, Sabuncu M et al..  2025.  A Deep-Learning Model for Multi-class Audio Classification of Vocal Fold Pathologies in Office Stroboscopy.. Laryngoscope.
Wong EWP, Sahin M, Yang R, Lee UJ, Li D, Zhan YA, Misra R, Tomas F, Alomran N, Polyzos A et al..  2025.  Disruption of TAD hierarchy promotes LTR co-option in cancer.. Nat Genet.
Sternberg CN, Hussain M.  2025.  Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer? Transl Cancer Res. 14(5):2536-2538.
Nepali PR, Gonzalez-Kozlova E, Anegondi M, Dogra N, Archer M, Chakraborty G, Tewari AK, Hopkins BD, Kyprianou N.  2025.  Effect of TGF-β mediated phenotypic changes on prostate cancer cell anoikis response.. Oncogene.